<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"efficiency":1,
"fine needle":2,
"nodule":1,
"one-stop thyroid nodule clinic":1,
"surgeon-performed":1,
"thyroid":19,
"Genomic instability":1,
"Proliferation":2,
"Rb-deficient cancers":1,
"Retinoblastoma":1,
"Survival pathways":1,
"Case report":2,
"Giant cell tumor":1,
"Larynx":1,
"Thyroid cartilage":1,
"Desmoplastic stroma reaction":1,
"Follicular thyroid cancer":2,
"HIF-1α":1,
"Hypoxia-associated proteins":1,
"Metastasis":4,
"Tenascin":1,
"Costal cartilage":1,
"Free flap":1,
"Thyroid cancer":20,
"Trachea":1,
"Tracheal reconstruction":1,
"Alcohols":1,
"Cancer":11,
"Cohort studies":1,
"Meta-analysis":2,
"Neoplasms":1,
"Quality of life":1,
"Surveys and questionnaires":1,
"Thyroid gland":1,
"Thyroid neoplasms":11,
"Validation studies":1,
"BRAF":3,
"Kirsten rat sarcoma":1,
"MET":1,
"anaplastic lymphoma kinase":1,
"epidermal growth factor receptor":2,
"non-small cell lung carcinoma":2,
"Carcinoma":2,
"Fine needle aspiration (FNA)":1,
"Indeterminate":2,
"Percutaneous":1,
"intravenous contrast agents":1,
"laser":1,
"lymphatic":1,
"metastases":2,
"ultrasound":8,
"AMAP1":1,
"CCL18":1,
"PITPNM3":1,
"Pyk2":1,
"breast cancer":10,
"Hashimoto’s thyroiditis":1,
"Papillary thyroid carcinoma":18,
"TSH":1,
"Thyroid cytology":3,
"Thyroid nodules":8,
"BRAF V600":1,
"Dabrafenib":1,
"Japanese":1,
"Malignant melanoma":1,
"Mutation":2,
"Solid tumor":1,
"Central lymph node dissection":1,
"Central lymph node metastasis":2,
"Papillary thyroid microcarcinoma":1,
"Cervical lymph nodes":1,
"Shear wave elastography":1,
"Ultrasonography":5,
"Anaplastic thyroid cancer":1,
"Anti-angiogenic inhibitor":1,
"Gastrointestinal perforation":1,
"Lenvatinib":3,
"Tyrosine kinase inhibitor":7,
"Central hyperthyroidism":1,
"Hyperthyroidism":2,
"Pituitary tumors":1,
"TSH-secreting pituitary adenoma":1,
"Thyrotropinoma":1,
"elastography":2,
"thyroid neoplasm":4,
"thyroid nodule":8,
"thyroid/parathyroid":1,
"differentiated radioiodine":1,
"refractory":1,
"Calcitonin":2,
"lung":1,
"medullary carcinoma":1,
"neuroendocrine tumor":1,
"Follicular variant of papillary thyroid carcinoma":1,
"Noninvasive follicular thyroid neoplasm with papillary-like nuclear features":1,
"Thyroid biopsy":1,
"Thyroid fine needle aspiration cytology":1,
"Thyroid histopathology":1,
"Thyroid ultrasound":2,
"Brain metastasis":1,
"Malignant glioma":1,
"Therapeutic anticoagulation":1,
"Venous thromboembolism":1,
"adipokine":1,
"cytokine":1,
"inflammation":1,
"prospective cohort":1,
"Cancer stem cell":1,
"Doxorubicin resistance":1,
"PRMT5":1,
"brown tumor":1,
"core biopsy":1,
"cytology":4,
"fine needle aspiration":2,
"hyperparathyroidism":1,
"renal cell carcinoma":1,
"Bethesda":1,
"indeterminate cytology":1,
"repeat FNA":1,
"unsatisfactory":1,
"incidence":1,
"medical overuse":1,
"overdiagnosis":1,
"screening":2,
"anaplastic thyroid carcinoma":3,
"posterior reversible encephalopathy syndrome":1,
"American Thyroid Association (ATA) guidelines":1,
"fine-needle aspiration cytology (FNAC)":1,
"Superb microvascular imaging":1,
"Bethesda system":1,
"thyroid ultrasonography":1,
"F18-choline":1,
"MIBI SPECT/CT":1,
"Minimally invasive surgery":1,
"PET/CT":2,
"Parathyroid adenoma":3,
"Primary hyperparathyroidism":2,
"2015 American Thyroid Association management guideline":1,
"Thyroid Imaging Reporting and Data System":1,
"artificial intelligence":1,
"computer-aided diagnosis system":1,
"Greece":1,
"Pathology":2,
"Registry":1,
"endoscopic thyroidectomy (ET)":1,
"gas-liquid mixing":1,
"tumescent solution":1,
"ESRP1":1,
"Metabolic gene expression":1,
"Mitochondrial DNA copy number":1,
"Mitochondrial DNA sequence imbalance":1,
"Triple negative breast cancer":1,
"Chernobyl":1,
"Cribriform morular":1,
"Radiation":2,
"Variant":1,
"African American":1,
"Hispanic American":1,
"Medicaid":1,
"North American Indian":1,
"insurance coverage":1,
"multivariate analysis":1,
"papillary carcinoma":4,
"tomography":1,
"differentiated thyroid cancer":1,
"postoperative period":1,
"prognosis":5,
"radioiodine therapy":1,
"time factors":1,
"treatment outcome":1,
"genetics":1,
"molecular diagnosis":1,
"EMT":1,
"FBW7":1,
"Migration and invasion":1,
"NSCLC":1,
"Snail":1,
"hypocalcemia":1,
"hypoparathyroidism":1,
"parathyroid glands":1,
"saline injection":1,
"thyroidectomy":4,
"CK-19":1,
"Galectin-3":3,
"Gene expression":3,
"HBME-1":1,
"Immunohistochemistry":4,
"PIWIL2":1,
"Cancer cells":1,
"PPARγ agonist":1,
"PPARγ antagonist":1,
"Therapeutic agents":1,
"Tumorigenicity":1,
"papillary thyroid cancer":1,
"precision medicine":1,
"radioactive iodine":2,
"refractory thyroid cancer":1,
"risk stratification":1,
"Cowden syndrome":1,
"FGF23":1,
"FN1-FGFR1":1,
"PTEN":1,
"Phosphaturic mesenchymal tumor":1,
"Tumor-induced osteomalacia":1,
"MEN2 syndrome":1,
"RET gene polymorphisms":1,
"associations analysis":1,
"haplotypes":1,
"medullary thyroid carcinoma":3,
"anaplastic":1,
"bias":1,
"continental population groups":1,
"ethnic groups":1,
"health care disparities":1,
"poverty":1,
"radiotherapy":2,
"thyroid carcinoma":3,
"Drug target":1,
"Grainyhead":1,
"Hepatocellular carcinoma":3,
"Oncogene":2,
"Stem cells":1,
"Liver cancer":2,
"Liver fibrogenesis":1,
"Thyroid hormone":1,
"Tumor microenvironment":3,
"Clinical outcome":1,
"Fast track cancer programs":1,
"Prospective study":1,
"Survival":5,
"Thyroid epidemiology":1,
"Cure models":1,
"Net survival":1,
"Probability of being cured":1,
"Time-to-cure":1,
"Eosinophilic abscess":1,
"Mastermind-like transcriptional coactivator 2":1,
"Salivary":1,
"Sclerosing mucoepidermoid carcinoma with eosinophilia":2,
"Microwave":1,
"Thermal ablation":2,
"Biopsy, fine-needle":1,
"Biopsy, large-core needle":1,
"iodide transporters":1,
"iodine":1,
"iodine metabolism":1,
"sodium iodide symporter (NIS)":1,
"NIFTP":1,
"molecular tests":1,
"risk of malignancy":1,
"RAS":1,
"biomarker":2,
"encapsulated follicular variant papillary thyroid carcinoma":1,
"American Indian/Alaska Native":1,
"cancer surveillance":1,
"health disparities":1,
"Fine needle aspiration cytology":1,
"Head and neck cancer":1,
"Oropharyngeal squamous cell carcinoma":1,
"P16 positive":1,
"Thyroid metastasis":1,
"FNA":2,
"direct smears":1,
"molecular testing":1,
"the Bethesda System":1,
"curved borders":1,
"infiltrative-type expansion":1,
"irregular borders":1,
"jagged edge":1,
"clinicopathological feature":1,
"columnar cell variant":1,
"paraneoplastic hyperthyroidism":1,
"β-hCG":1,
"PAX-8":1,
"ectopic":1,
"squamous cell carcinoma":1,
"thyroglobulin":2,
"thyrotropin":2,
"Elongated quinary patterns":1,
"Higher order spectra":1,
"Particle swarm optimization":1,
"Support vector machine":1,
"local anaesthesia":1,
"non-diagnostic sample":1,
"sedation":1,
"Ligament of Berry":1,
"laryngeal":1,
"nerve":1,
"recurrent":1,
"oncology":1,
"psychosocial distress":1,
"quality of care":1,
"anti-Müllerian hormone":1,
"ionizing radiation":1,
"ovarian reserve":1,
"Ecografía tiroidea":1,
"Nódulo tiroideo":1,
"TI-RADS":1,
"Tiroidectomía":1,
"tumor profiling":1,
"Cancer du sein":1,
"Graves’ disease":2,
"Hyperthyroïdie":1,
"Maladie de Basedow":1,
"Thyroxine":1,
"Triiodothyronine":1,
"Multifocality":1,
"Tumor foci":1,
"RFA":1,
"cystic nodule":1,
"nodule shrinkage":1,
"toxic nodule":1,
"Granular cell tumor":1,
"Pituicytoma":1,
"Posterior pituitary tumor":1,
"Spindle cell oncocytoma":1,
"WHO classification of endocrine tumors":1,
"Case series":1,
"Pediatric":1,
"Tracheal paraganglioma":1,
"PKM2":1,
"SREBP-1a":1,
"cell proliferation":1,
"gene transcription":1,
"lipid metabolism":1,
"lipid synthesis":1,
"lipogenesis":1,
"pyruvate kinase":1,
"sterol regulatory element–binding protein":1,
"Head and neck tumors":1,
"Heavy metals":1,
"Oncogenesis":1,
"PCB":1,
"Diagnostic":1,
"individualized":1,
"signature":1,
"MiR-577":1,
"Rab25":1,
"epithelial-mesenchymal transition":3,
"Dose-escalation":1,
"IMRT":1,
"Locally advanced differentiated thyroid cancer":1,
"Medullary thyroid cancer":3,
"Characteristics":1,
"Intracystic papillary carcinoma":1,
"suppressors of cytokine signaling 1":1,
"6PGD":1,
"NDAH":1,
"NDAPH":1,
"Physcion":1,
"SIRT1":1,
"BRAF mutation":1,
"CD56":1,
"CK19":1,
"papillary thyroid micro-carcinoma":1,
"thyroid peroxidase":1,
"Epidemiology":1,
"serum AMPD1":1,
"oncology nurse":1,
"Docking":1,
"Focused library":1,
"RET kinase":1,
"Virtual screening":1,
"BRAF-activated non-protein coding RNA":1,
"Raf":1,
"extracellular-signal-regulated protein kinase":1,
"mitogen-activated protein kinase kinase":1,
"HRAS proto-oncogene":1,
"case-control":1,
"intron":1,
"variants":1,
"Neuroendocrine carcinoma":1,
"Poorly differentiated":1,
"Small cell lung carcinoma":1,
"p16":1,
"Computer-assisted":1,
"Pattern recognition":1,
"Radionuclide imaging":1,
"Echogenic areas":1,
"Bethesda classification":1,
"atypia of undetermined significance (AUS)/follicular lesion of undetermined significance (FLUS)":1,
"fine-needle aspiration cytology":1,
"follicular neoplasm (FN)/suspicious for follicular neoplasm (SFN)":1,
"malignancy risk":1,
"metastatic lesions to the brain":1,
"predictive factors":1,
"whole-brain radiotherapy alone":1,
"Kuma Hospital":1,
"active surveillance":2,
"papillary microcarcinoma":1,
"complication":1,
"elderly":1,
"mortality":1,
"JARID1A":1,
"KDM5A":1,
"epigenetics":1,
"genetically engineered mouse models":1,
"metastatic angiosarcoma":1,
"Antiangiogenic":1,
"VEGF":1,
"VEGFR":1,
"nephropathy":1,
"proteinuria":1,
"renal failure":1,
"salivary gland cancer":1,
"toxicity":1,
"NTRK gene fusions":1,
"TRKA":1,
"TRKB":1,
"TRKC":1,
"neurotrophin":1,
"Cervical oesophageal cancer":1,
"Complete block":1,
"Directional block":1,
"Helical tomotherapy":1,
"Intensity-modulated radiation therapy":1,
"Lung dose":1,
"neoplasm metastasis":1,
"TNM staging":1,
"lymph node":1,
"Fibrinogen":1,
"Lymph node metastasis":1,
"Recurrence":2,
"Cell cycle progression":1,
"Paired box gene 8 (PAX8)":1,
"Papillary thyroid carcinoma (PTC)":1,
"miR-144-3p":1,
"ERBB1":1,
"ERBB2":1,
"MTC":1,
"immunofluorescence":1,
"parafollicular C cells":1,
"secretory granules":1,
"transmission electron microscopy":1,
"ultrastructure":1,
"Breast":1,
"131Iodine whole-body scan":1,
"differentiated thyroid carcinoma":2,
"Metabolic bone disease":1,
"metabolic superscan":1,
"thyrotoxicosis":1,
"ER oestrogen receptor":1,
"ER+ ER positive":1,
"ER− ER negative":1,
"GSL glucosinolate":1,
"ITC isothiocyanate":1,
"PR progesterone receptor":1,
"PR+ PR positive":1,
"PR− PR negative":1,
"Case–control studies":1,
"Cruciferous vegetables":1,
"Glucosinolates":1,
"Isothiocyanates":1,
"checkpoint inhibitor":1,
"hypothyroidism":2,
"risk factor":1,
"sunitinib":1,
"endocrine tumours":1,
"betel quid":1,
"centenarians":1,
"dietary":1,
"lifestyle":1,
"nut":1,
"red meat":1,
"F-18 FDG avidity":1,
"I-131 avidity":1,
"Lung metastasis":2,
"Macronodular":1,
"Micronodular":1,
"18F-Fluorocholine":1,
"18F-Fluorodeoxyglucose":1,
"Cholecystokinin receptor subtype 2":1,
"Minigastrin analogue":1,
"Molecular docking":1,
"focal adhesion kinase":1,
"predictive markers":1,
"tumour progression":1,
"head and neck surgery":1,
"otolaryngology / ENT":1,
"surgery":2,
"surgical oncology":1,
"Cardiac myxoma":1,
"Carney complex":1,
"Thyroid adenoma":1,
"mucin expression":1,
"non-small cell lung cancer":1,
"pancreatic ductal adenocarcinoma":1,
"indolent":1,
"Estrogen":1,
"Estrogen receptors":1,
"SPRED1":1,
"miR-196a":1,
"children":1,
"cytopathology":1,
"head and neck":1,
"Cytokeratin-19":1,
"Hector Battifora mesothelial-1":1,
"malignant":1,
"nonmalignant":1,
"Dehydrated ethanol":1,
"Spontaneously rupture":1,
"TCGA":1,
"kallikreins":1,
"BRAF V600E":1,
"integrated analyses":1,
"microRNA":1,
"transcriptome sequencing":1,
"chemotherapy":3,
"postoperative radiotherapy":1,
"18F-fluorodeoxyglucose positron emission tomography/computed tomography":1,
"Birt–Hogg–Dubé syndrome":1,
"chromophobe renal cell carcinoma":1,
"hurtle cell thyroid cancer":1,
"Minimally invasive":1,
"Peritoneal strumosis":1,
"Struma ovarii":1,
"Carcinoma, papillary":1,
"Extranodal extension":1,
"Ultrasonography, mammary":1,
"digital image analysis":1,
"invasion":2,
"programmed death-ligand 1":2,
"protein biomarker":1,
"Bijeljina":1,
"lymph nodes":1,
"papillary":1,
"bioinformatics":1,
"functional enrichment analysis":1,
"osteosarcoma":1,
"sorafenib":1,
"Epithelial mesenchymal transition":1,
"Interleukin-11":1,
"Invasion and metastasis":1,
"Central lymph nodes":1,
"Prelaryngeal lymph nodes":1,
"Superior mediastinum lymph nodes":1,
"Gd–Au NCs":1,
"Glypican-1":1,
"fluorescence imaging":1,
"magnetic resonance imaging":1,
"pancreatic cancer":1,
"CDC73":1,
"HPT-JT":1,
"early onset":1,
"large genomic deletion":1,
"mastectomy":1,
"synchronous cancer":1,
"Helicobacter pylori":1,
"Lymphoma":1,
"Neoplasms, multiple primary":1,
"apoptosis":2,
"metformin":1,
"nude rats":1,
"lateral cervical lymph node metastasis":1,
"lymph node jump metastasis":1,
"collagen triple helix repeat containing 1":1,
"carbon nanoparticles":1,
"risk factors":1,
"younger patients":1,
"American Thyroid Association":1,
"guidelines":1,
"microPLIC":1,
"microPTC":1,
"adrenal insufficiency":1,
"hypopituitarism":1,
"pituitary carcinoma":1,
"pituitary surgery":1,
"prolactinoma":1,
"active surveillance (AS)":1,
"Laryngectomy":1,
"Neck dissection":1,
"Choroid":1,
"ciliary body":1,
"eye":1,
"iris":1,
"uvea":1,
"Abdominal ultrasound":1,
"positron-emission tomography/computed tomography scan":1,
"primary Choroidal melanoma":1,
"staging":1,
"Dysthyroidism":1,
"Tyrosine kinase inhibitors":1,
"H-FLAC":1,
"L-FLAC":1,
"fetal adenocarcinoma":1,
"lung cancer":1,
"outcomes":1,
"p53":1,
"Desmoid-type fibromatosis":1,
"calcifications":1,
"histopahology":1,
"tumor":1,
"APCL":1,
"Panobinostat":1,
"Wnt/β-catenin signaling pathway":1,
"4T1 mammary carcinoma":1,
"Respiratory hyperoxia therapy":1,
"T-cell immune-suppression":1,
"hypoxia":1,
"myeloid-derived suppressor cells":1,
"tumor immunity":1,
"cancer risk":1,
"colorectal cancer":1,
"levothyroxine":1,
"thyroid hormones":1,
"anaplastic carcinoma":1,
"capsule":1,
"carcinosarcoma":1,
"good prognosis":1,
"noninvasive":1,
"Immunomodulation":1,
"Immunotherapy":1,
"Nanoparticles":1,
"Vaccines":1,
"HAX-1":1,
"migration":1,
"Spindle cells":1,
"embryonic remnants":1,
"epithelial-mesenchymal transformation":1,
"multinodular goiter":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2018年4月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
